British Journal of Ophthalmology 2003;87:1229-1231
© 2003 BMJ Publishing Group Ltd
Defining and measuring treatment outcome in unilateral amblyopia
C E Stewart,
M J Moseley,
A R Fielder
Department of Ophthalmology, Imperial College, London, UK
Correspondence to: Correspondence to: Catherine Stewart, Department of Ophthalmology, Imperial College, London, 9L01, Charing Cross Hospital, St Dunstans Road, London W6 8RF, UK; c.stewart{at}imperial.ac.uk
ABSTRACT
Aim: To offer a critique of current methods of defining amblyopia treatment outcome and to examine alternative approaches.
Method: Literature appraisal and descriptive case presentations.
Results: Currently, the outcome of amblyopia treatment is expressed as the number of acuity chart lines gained or, alternatively, achievement of an arbitrarily adopted level of visual acuity. As binocular vision is optimised with equal visual input from each eye the authors propose that the optimum outcome of amblyopia therapy is to achieve a visual acuity in the amblyopic eye equal to that of its fellow. In addition, improvement should be graded as the proportion of change in visual acuity with respect to the absolute potential for improvement (that is, that pertaining in the fellow eye at end of treatment).
Conclusions: There are two methods of appropriately describing the outcome of amblyopia treatment: firstly, by the difference in final visual acuity of amblyopic and fellow eye (residual amblyopia); secondly, the proportion of the deficit corrected.
Keywords: treatment outcome; unilateral amblyopia; children
This article has been cited by other articles:

|
 |

|
 |
 
C. E Stewart, D. A Stephens, A. R Fielder, M. J Moseley, and ROTAS Cooperative
Objectively monitored patching regimens for treatment of amblyopia: randomised trial
BMJ,
October 6, 2007;
335(7622):
707 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Stewart, A. R. Fielder, D. A. Stephens, M. J. Moseley, and MOTAS Cooperative
Treatment of Unilateral Amblyopia: Factors Influencing Visual Outcome
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3152 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Awan, F. A Proudlock, and I. Gottlob
A Randomized Controlled Trial of Unilateral Strabismic and Mixed Amblyopia Using Occlusion Dose Monitors to Record Compliance
Invest. Ophthalmol. Vis. Sci.,
April 1, 2005;
46(4):
1435 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Stewart, M. J. Moseley, D. A. Stephens, and A. R. Fielder
Treatment Dose-Response in Amblyopia Therapy: The Monitored Occlusion Treatment of Amblyopia Study (MOTAS)
Invest. Ophthalmol. Vis. Sci.,
September 1, 2004;
45(9):
3048 - 3054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R O'Connor, T J Stephenson, A Johnson, M J Tobin, S Ratib, M Moseley, and A R Fielder
Visual function in low birthweight children
Br. J. Ophthalmol.,
September 1, 2004;
88(9):
1149 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|